Contributor Page
Smart & Biggar/Fetherstonhaugh
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 5935514
Fax: +1 416 5911690
1100-150 York Street
ON M5H 3S5
By Kohji Suzuki, Jamie-Lynn Kraft
In the wake of the 2014 announcement that the Canadian Trademarks Act would undergo significant overhaul, there was much speculation about how the changes would impact the behaviour of those filing trademark applications in Canada.
By Kwan Loh, Graham Hood, John Sparks
The Canadian federal government is moving quickly towards legalizing the possession and consumption of cannabis for recreational purposes.
By Urszula Wojtyra
The Federal Court of Appeal affirmed that, under the Patent Act, a successful patentee always has a right to its damages, and only it has the right to elect an accounting of profits, subject to the court's discretion.
By Brandon Heard
Dunphy J. relied on the doctrines of issue estoppel and collateral attack in denying Sanofi and Schering leave to amend.
By Katie Lee
On January 30, 2018, the Government of Canada posted the Comprehensive and Progressive Partnership for Trans-Pacific Partnership (CPTPP) - Backgrounder.
By Katie Lee
In its Common Drug Review (CDR) Update – Issue 133 (with further details in Revisions to CADTH's Biosimilar and Resubmission Processes, Other Administrative Changes...
By Andrew Mandlsohn
On February 6, 2018, the Patented Medicine Prices Review Board (PMPRB) announced the publication of the most recent edition of its series of reports on generic drug pricing.
By Andrew Mandlsohn
On February 7, 2018, Health Canada published an update to the guidance document Classification of Products at the (Medical) Device-Drug Interface.
By Abigail Smith
On February 8, 2018, the Federal Court of Appeal issued public reasons for its decision dismissing Teva's appeal relating to the damages and costs awarded against it for its infringement of Janssen's patent for levofloxacin ...
By Kwan Loh, Graham Hood
The Canadian federal government is moving quickly towards legalizing the possession and consumption of cannabis for recreational purposes. However, Canada's cannabis industry is already "overgrown" ...
By Guillaume Lavoie Ste-Marie
On February 20, 2018, the Federal Court of Appeal issued its judgment in Bell Canada v Lackman (2018 FCA 42), declaring that an interim injunction authorising the shutdown and seizure of piracy websites ...
By Andrea Kroetch
For a few weeks every two years, the Summer and Winter Olympic Games offer brand owners and advertisers the opportunity to reach billions of people in hundreds of countries.
By Kevin Siu
We previously reported that the Federal Court dismissed a Patented Medicines (Notice of Compliance) (PMNOC) Regulations application relating to Apotex's generic aripiprazole product...
By Urszula Wojtyra
On January 18, 2018, Health Canada and the Institute for Safe Medication Practices Canada (ISMP Canada) opened its consultation on different approaches to the naming of biologic drugs...
By Katie Lee
As previously reported, Health Canada announced January 1, 2018 as the proposed date for mandatory filing of specified regulatory activity.